Help protect against pneumococcal pneumonia

1. Australian Government, Department of Health. Health Topics: Pneumococcal Disease. [accessed February 2020]. 2. Menzies R et al. Vaccine myopia: adult vaccination also needs attention. Med J Aust. 2017;206(6):2.e1. 3. Earle K et al. Burden of pneumococcal disease in adults aged 65 years and older: an Australian perspective. Pneumonia (Nathan). 2016;8:9. 4. Australian Government Department of Health. The Australian Immunisation Program: Older Australians. [accessed February 2020]. 5. Health Stats NSW Influenza and pneumococcal disease immunisation by age, trend. 6. Family Medicine Research Centre. University of Sydney. SAND abstract No. 223 from the BEACH program. Sydney: FMRC University of Sydney, 2014. [accessed February 2020]. 7. Australian Government, Department of Health. Pharmaceutical Benefits Scheme. [accessed February 2020].

Seqirus (Australia) Pty Ltd. 63 Poplar Road, Parkville, VIC 3052. ABN 66 120 398 067. Medical Information: 1800 642 865. Pneumovax® is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ, USA. Seqirus™ is a trademark of Seqirus UK Limited or its affiliates.

Date of preparation: March 2020. SEQ/PNEU/1218/012(1) 
Privacy statement: Information regarding Seqirus’ handling of personal information is available at You are receiving this email because you registered your interest in the Community Immunity website.


Join APNA as a member

Only $26.50 per month for professionals!


The Australian Primary Health Care Nurses Association acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.

© Copyright 2024 Australian Primary Health Care Nurses Association (APNA). All rights reserved. MRM by Bond Software.


Item removed. Undo